What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Antibody
The scientist’s investigation covers issues in Immunology, Vaccination, Streptococcus pneumoniae, Virology and Conjugate vaccine.
His work on Immunology is being expanded to include thematically relevant topics such as Meningococcal disease.
The various areas that David Goldblatt examines in his Vaccination study include Immunization, Pediatrics and Antibody titer.
His Streptococcus pneumoniae research incorporates themes from Carriage, Serotype, Microbiology and Antigen.
While the research belongs to areas of Virology, David Goldblatt spends his time largely on the problem of Haemophilus influenzae, intersecting his research to questions surrounding Whooping cough.
David Goldblatt combines subjects such as Pneumococcal conjugate vaccine and Licensure with his study of Conjugate vaccine.
His most cited work include:
- The fundamental link between pneumococcal carriage and disease (388 citations)
- Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. (307 citations)
- Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study (302 citations)
What are the main themes of his work throughout his whole career to date?
David Goldblatt mainly focuses on Immunology, Vaccination, Antibody, Virology and Streptococcus pneumoniae.
Much of his study explores Immunology relationship to Pneumococcal conjugate vaccine.
David Goldblatt focuses mostly in the field of Pneumococcal conjugate vaccine, narrowing it down to topics relating to Pediatrics and, in certain cases, Pneumonia, Incidence and Chronic granulomatous disease.
David Goldblatt has researched Vaccination in several fields, including Immunization, Haemophilus influenzae and Meningococcal disease.
His Antibody research is multidisciplinary, incorporating elements of Immunity and Antigen.
His Streptococcus pneumoniae study combines topics in areas such as Carriage and Colonisation, Colonization, Microbiology.
He most often published in these fields:
- Immunology (53.54%)
- Vaccination (23.51%)
- Antibody (24.36%)
What were the highlights of his more recent work (between 2016-2021)?
- Immunology (53.54%)
- Antibody (24.36%)
- Streptococcus pneumoniae (20.11%)
In recent papers he was focusing on the following fields of study:
David Goldblatt mostly deals with Immunology, Antibody, Streptococcus pneumoniae, Vaccination and Pneumococcal conjugate vaccine.
The concepts of his Antibody study are interwoven with issues in Severe acute respiratory syndrome coronavirus 2, Immunity, Antigen and Virology.
His Streptococcus pneumoniae research integrates issues from Colonisation and Microbiology.
In his study, Routine vaccination, Incidence and Pneumococcal infections is strongly linked to Carriage, which falls under the umbrella field of Vaccination.
He interconnects Booster dose, Internal medicine, Randomized controlled trial, Immunogenicity and Pediatrics in the investigation of issues within Pneumococcal conjugate vaccine.
His Pediatrics research is multidisciplinary, relying on both Tetanus and Diphtheria.
Between 2016 and 2021, his most popular works were:
- Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial. (62 citations)
- Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration (55 citations)
- Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens (54 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Antibody
David Goldblatt spends much of his time researching Immunology, Antibody, Vaccination, Streptococcus pneumoniae and Antigen.
His work carried out in the field of Immunology brings together such families of science as Streptococcus vaccine and Disease.
His Antibody research incorporates elements of Streptococcus, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019 and Immunity.
His work on Influenza vaccine is typically connected to Pneumococcal polysaccharide vaccine as part of general Vaccination study, connecting several disciplines of science.
His Streptococcus pneumoniae research is multidisciplinary, incorporating perspectives in Internal medicine, Microbiology and Serum samples.
His biological study spans a wide range of topics, including Virology, Pneumococcal vaccine, Adverse effect, Polysaccharide and Pneumococcal conjugate vaccine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
